Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Floquet

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Efficacy and tolerability of the ifosfamide-epirubicin combination in relapsed ovarian cancerF Joly, H Bourgeois, A Floquet, et al.
Gynecologic Oncology|November 6, 2007
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancerA Goncalves, M Fabbro, C Lhommé, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Number of residual nodules, better than size, defines optimal surgery in advanced epithelial ovarian cancerE Stoeckle, P Paravis, A Floquet, et al.
American Journal of Clinical Oncology|April 1, 1995
A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinomaM Caudry, C Bonnel, A Floquet, et al.
Talanta|February 15, 2011
Nanomolar detection with high sensitivity microfluidic absorption cells manufactured in tinted PMMA for chemical analysisCedric F A Floquet, Vincent J Sieben, Ambra Milani, et al.
Analytica Chimica Acta|October 31, 2015
Characterisation and deployment of an immobilised pH sensor spot towards surface ocean pH measurementsJennifer S Clarke, Eric P Achterberg, Victoire M C Rérolle, et al.
Analytica Chimica Acta|June 25, 2013
Development of a colorimetric microfluidic pH sensor for autonomous seawater measurementsVictoire M C Rérolle, Cedric F A Floquet, Andy J K Harris, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapyM J Piccart, A Floquet, G Scarfone, et al.
British Journal of Cancer|April 25, 2013
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECOI Ray-Coquard, L Favier, B Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trialsA Doussau, R Thiébaut, B Geoerger, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Efficacy and tolerability of the ifosfamide-epirubicin combination in relapsed ovarian cancerF Joly, H Bourgeois, A Floquet, et al.
Gynecologic Oncology|November 6, 2007
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancerA Goncalves, M Fabbro, C Lhommé, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Number of residual nodules, better than size, defines optimal surgery in advanced epithelial ovarian cancerE Stoeckle, P Paravis, A Floquet, et al.
American Journal of Clinical Oncology|April 1, 1995
A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinomaM Caudry, C Bonnel, A Floquet, et al.
Talanta|February 15, 2011
Nanomolar detection with high sensitivity microfluidic absorption cells manufactured in tinted PMMA for chemical analysisCedric F A Floquet, Vincent J Sieben, Ambra Milani, et al.
Analytica Chimica Acta|October 31, 2015
Characterisation and deployment of an immobilised pH sensor spot towards surface ocean pH measurementsJennifer S Clarke, Eric P Achterberg, Victoire M C Rérolle, et al.
Analytica Chimica Acta|June 25, 2013
Development of a colorimetric microfluidic pH sensor for autonomous seawater measurementsVictoire M C Rérolle, Cedric F A Floquet, Andy J K Harris, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapyM J Piccart, A Floquet, G Scarfone, et al.
British Journal of Cancer|April 25, 2013
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECOI Ray-Coquard, L Favier, B Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trialsA Doussau, R Thiébaut, B Geoerger, et al.
Pageof 5